Key TakeawaysMFN tariffs could reshape drug pricing and access, with potential long-term implications depending on legislative changes and voluntary agreements.DTC channels disrupt traditional pharmacy operations, raising compliance concerns and altering the dynamics of drug pricing and patient access.The 340B program’s pricing dynamics are linked to MFN, affecting hospital revenues and potentially leading to service reevaluations.Policy […]
